Disappointing economic data from China sent the markets plummeting with the Dow skidding 356 points to 16,171. Nasdaq slumped 88 points to 4,688.
On the upside
Trevena (Nasdaq: TRVN) announced positive Phase 2b study results of its moderate to severe acute postoperative pain treatment TRV130.
Stereotaxis (Nasdaq: STXS) received a patent for data transmission across a network to a high-resolution display facilitating the management of medical procedures.
Steven Cohen’s Point72 Asset Management acquired a 5.1% stake in SunEdison (NYSE: SUNE).
On the downside
GoPro (Nasdaq: GPRO) introduced a new feature to trim and share short video clips but the stock price fell.
Netflix (Nasdaq: NFLX) did not renew its content deal with Epix.
Bloomberg noted that the average yield of Freeport-McMoRan’s (Nasdaq: FCX) bonds were higher than junk bonds.
In the broad market, declining issues outpaced advancers by a margin of nearly 9 to 1 on both the NYSE and on Nasdaq. The broader S&P 500 plummeted 41 points to 1,930. Bitcoin slipped $1 to $227.
